Early Morning Insomnia with Rapidly Eliminated Benzodiazepines
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
Early morning insomnia, a significant increase in wakefulness during the final hours of drug nights, occurred after 1 or 2 weeks of nightly administration of benzodiazepine hypnotics with short elimination half-lives, when tolerance had begun to develop. Early morning insomnia may be a variant of rebound insomnia and therefore specific to benzodiazepines, or it may occur with any rapidly eliminated sedative-hypnotic agent.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, early-morning insomnia associated with short-acting benzodiazepines triazolam and midazolam markedly worsened after 7 days of treatment [43].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [43]
In the citing paper
“Other new withdrawal symptoms that may be more specific to a certain class of CNS drugs include lacrimation, rhinorrhea, and sneezing for opiates, paroxysmal sweats for alcohol, and increased appetite for nicotine [10,23,24] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [23]
In the citing paper
“Rebound with short-acting drugs may be best illustrated by withdrawal from cocaine and heroin, which both have a rapid onset and brief duration of action [10,23] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [23]
In the citing paper
“Persistent postwithdrawal disorders have been described with different classes of CNS drugs (e.g.protracted insomnia for alcohol and benzodiazepine withdrawal [10,36] and major depression/dysphoria for cocaine and amphetamine withdrawal [10,23] ), and even more so with specific drugs (e.g.quetiapine and paroxetine) within a drug class [6,15,16,33] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [23]
Citations
Cites
Multiple comparisons among means
Dunn, O. J. (1961) · Journal of the American Statistical Association · doi:10.1080/01621459.1961.10482090 · Cited by 5,006
Rebound Insomnia: A New Clinical Syndrome
Kales, A., Scharf, M. B., & Kales, J. D. (1978) · Science · doi:10.1126/science.684426 · Cited by 200
Self-citationRebound Insomnia and Rebound Anxiety: A Review
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (2008) · Pharmacology · doi:10.1159/000137794 · Cited by 198
Self-citationKinetics and clinical effects of flurazepam in young and elderly noninsomniacs
Greenblatt, D. J., Divoll, M., Harmatz, J. S., MacLaughlin, D. S., & Shader, R. I. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.191 · Cited by 150
Anxiety caused by a short-life hypnotic.
Morgan, K., & Oswald, I. (1982) · BMJ · doi:10.1136/bmj.284.6320.942 · Cited by 137
Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines
Kales, A. (1979) · JAMA · doi:10.1001/jama.241.16.1692 · Cited by 136
Self-citationAlcohol and sleep in young adults
Rundell, O. H., Lester, B. K., Griffiths, W. J., & Williams, H. L. (1972) · Psychopharmacology · doi:10.1007/bf00422697 · Cited by 120
Blood Level Profile in Man following Chronic Oral Administration of Flurazepam Hydrochloride
Kaplan, S. A., de Silva, J. A. F., Jack, M. L., Alexander, K. M., Strojny, N., Weinfeld, R. E., Puglisi, C. V., & WEISSMAN, L. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600621205 · Cited by 103
Hypnotic Efficacy of Triazolam: Sleep Laboratory Evaluation of Intermediate‐Term Effectiveness
KALES, A., KALES, J. D., BIXLER, E. O., SCHARF, M. B., & RUSSEK, E. (1976) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1976.tb02414.x · Cited by 99
Self-citationHypnotic Drugs and Their Effectiveness: All-night EEG Studies of Insomniac Subjects
Kales, A. (1970) · Archives of General Psychiatry · doi:10.1001/archpsyc.1970.01750030034006 · Cited by 98
Self-citation
Research works printed but not linked: 3
- BRAESTRUP, C, BENZODIAZEPINE RECEPTORS, ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 30: 852 (1980).
- METZLER, C.M., BIOAVAILABILITY AND PHARMACOKINETICS OF ORALLY-ADMINISTERED TRIAZOLAM IN NORMAL SUBJECTS, CLINICAL PHARMACOLOGY & THERAPEUTICS 21: 111 (1977).
- Oswald, I., Pharmacology of the States of Alertness: 51 (1979).
Cited by
Meta-analysis of benzodiazepine use in the treatment of insomnia.
(2000) · PubMed Central · Cited by 613
Midazolam A Review of its Pharmacological Properties and Therapeutic Use
Dundee, J. W., Halliday, N. J., Harper, K. W., & Brogden, R. N. (1984) · Drugs · doi:10.2165/00003495-198428060-00002 · Cited by 359
Desforges, J. F., Prinz, P. N., Vitiello, M. V., Raskind, M. A., & Thorpy, M. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230805 · Cited by 318
Kanto, J. H. (1985) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1985.tb03411.x · Cited by 237
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“Importantly, early-morning insomnia associated with shortacting benzodiazepines triazolam and midazolam markedly worsened after 7 days of treatment [43].”
BackgroundWoods, J. H., & Winger, G. (1995) · Psychopharmacology · doi:10.1007/bf02245824 · Cited by 196
Ankier, S. I., & Goa, K. L. (1988) · Drugs · doi:10.2165/00003495-198835010-00003 · Cited by 189
Quazepam: Hypnotic Efficacy and Side Effects
Kales, A. (1990) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02545.x · Cited by 188
Self-citationRebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
Evaluation and Treatment of Insomnia
Kales, J. D., & Kales, A. (1987) · Psychiatric Annals · doi:10.3928/0048-5713-19870701-08 · Cited by 165
Self-citationNew Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia
Walsh, J. K., Vogel, G. W., Scharf, M. B., Erman, M. K., Erwin, C. W., Schweitzer, P. K., Mangano, R. M., & Roth, T. G. (2000) · Sleep Medicine · doi:10.1016/s1389-9457(99)00006-4 · Cited by 122
Precipitated diazepam withdrawal in baboons: Effects of dose and duration of diazepam exposure
Lukas, S. E., & Griffiths, R. R. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90218-8 · Cited by 97
Vermeeren, A., Danjou, P. E., & O'Hanlon, J. F. (1998) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(1998110)13:2+<s98::aid-hup54>3.0.co;2-1 · Cited by 94
Rational Use of Benzodiazepines in the Elderly
Shorr, R. I., & Robin, D. W. (1994) · Drugs & Aging · doi:10.2165/00002512-199404010-00002 · Cited by 96
“Secondly, early morning awakening has been described after the bedtime administration of ultrashort half-life benzodiazepines (Kales et al. 1983), presumably due to drug withdrawal.”
BackgroundVoderholzer, U., Riemann, D. W., Hornyak, M., Backhaus, J., Feige, B., Berger, T., & Hohagen, F. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170045 · Cited by 86
“Since triazolam’s potential to induce rebound insomnia was partly explained by its rapid elimination ( Kales et al. 1983 a, 1986, 1990, Bixler et al. 1985), it is of great interest to investigate possible rebound effects after abrupt withdrawal of zopiclone and zolpidem, since these drugs are also rapidly eliminated.”
BackgroundInfluentialSleep Disorders: Insomnia, Sleepwalking, Night Terrors, Nightmares, and Enuresis
KALES, A., SOLDATOS, C. R., & KALES, J. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-582 · Cited by 77
Self-citationBenzodiazepines and caffeine: effect on daytime sleepiness, performance, and mood
Johnson, L. C., Spinweber, C. L., & Gomez, S. A. (1990) · Psychopharmacology · doi:10.1007/bf02244120 · Cited by 80
Nocturnal Sleep and Wakefulness: Effects of Age and Sex in Normal Sleepers
Bixler, E. O., Kales, A., Jacoby, J. A., Soldatos, C. R., & Vela-bueno, A. (1984) · International Journal of Neuroscience · doi:10.3109/00207458408985343 · Cited by 74
Self-citationHypnotics in the Elderly: What Cause for Concern?
Morgan, K. (1990) · Drugs · doi:10.2165/00003495-199040050-00004 · Cited by 73
Benzodiazepine dependence in the clinic: reason for anxiety?
Nutt, D. J. (1986) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(86)90420-7 · Cited by 75
Sundown Syndrome in Severely Demented Patients with Probable Alzheimer's Disease
Little, J. T., Satlin, A., Sunderland, T., & Volicer, L. (1995) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879500800205 · Cited by 70
Relative abuse liability of triazolam: Experimental assessment in animals and humans
Griffiths, R. R., Lamb, R. J., Ator, N. A., Roache, J. D., & Brady, J. V. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90039-9 · Cited by 71
Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol
Adam, K., Oswald, I., & Shapiro, C. M. (1984) · Psychopharmacology · doi:10.1007/bf00427692 · Cited by 74
“The immediate apparance of intense withdrawal symptoms after triazolam leads to the supposition that such symptoms would be likely during each day after nightly triazolam, and we have described anxiety by day as an apparent feature of intake of triazolam 0.5 mg (Morgan and Oswald 1982), our observations since being co…”
BackgroundResultInfluentialLangley, M. S., & Clissold, S. P. (1988) · Drugs · doi:10.2165/00003495-198835020-00002 · Cited by 63
Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants.
Berney, A., Stiefel, F., Mazzocato, C., & Buclin, T. (2000) · PubMed · doi:10.1007/s005200000154 · Cited by 64
“Short-acting benzodiazepines, such as triazolam or midazolam, may not have a long enough duration of action and can then lead to early-morning insomnia, daytime anxiety, tension or panic; amnesia, rebound and withdrawal difficulties are also associated with shortacting compounds [ 35 , 72].”
The biological basis of benzodiazepine dependence
Lader, M., & File, S. (1987) · Psychological Medicine · doi:10.1017/s0033291700025794 · Cited by 59
“This has been reported following one or two weeks administration of short-acting benzodiazepine hypnotics (Kales et al. 1983 ft).”
BackgroundManagement of Insomnia in Hospitalized Patients
Berlin, R. M. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-3-398 · Cited by 58
Adverse effects of Benzodiazepines
Gudex, C. M. (1991) · Social Science & Medicine · doi:10.1016/0277-9536(91)90216-y · Cited by 68
Dose response curve for the phase-shifting effect of triazolam on the mammalian circadian clock
Turek, F. W., & Losee-Olson, S. H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90564-9 · Cited by 54
Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use
Dokkedal‐Silva, V., Berro, L. F., Galduróz, J. C. F., Tufik, S. B., & Andersen, M. L. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000227 · Cited by 62
Acute Administration of Triazolam for the Daytime Sleep of Rotating Shift Workers
Walsh, J. K., Muehlbach, M. J., & Schweitzer, P. K. (1984) · Sleep · doi:10.1093/sleep/7.3.223 · Cited by 52
The Place of Benzodiazepines in Psychiatric Practice
Tyrer, P., & Murphy, S. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.6.719 · Cited by 52
Hypnotics and sleep physiology: A consensus repot
Borbély, A. A., Åkerstedt, T., Benoit, O., Holsboer, F., & Oswald, I. (1991) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02193749 · Cited by 52
“During prolonged administration of hypnotics, increaed restlessness in the last part of sleep (Ogunremi et al. 1973) and early morning awakening have been reported (Kales et al. 1983b).”
BackgroundScharf, M. B., Roth, P. B., Dominguez, R. A., & Ware, J. C. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03486.x · Cited by 46
Alprazolam: Effects on Sleep and Withdrawal Phenomena
Kales, A., Bixler, E. O., Vela‐Bueno, A., Soldatos, C. R., & Manfredi, R. L. (1987) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1987.tb03058.x · Cited by 46
Self-citationMAMELAK, M., CSIMA, A., & PRICE, V. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb02767.x · Cited by 45
Hypnosedatives in the Elderly: A Guide to Appropriate Use
Woodward, M. C. (1999) · CNS Drugs · doi:10.2165/00023210-199911040-00003 · Cited by 42
“[82,83] Withdrawal effects have been a particular concern with triazolam[84-86] and have been labelled the ‘triazolam syndrome’, characterised by antegrade anorexia, delirium, transient agitation and psychotic symptoms.”
BackgroundThe natural history of tolerance to the benzodiazepines
Higgitt, A., Fonagy, P., & Lader, M. (1988) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000412 · Cited by 37
Comparative Study on Benzodiazepine Use in Canada and Chile
Ruiz, I., Offermanns, J., Lanctôt, K. L., & Busto, U. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03931.x · Cited by 33
A double‐blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly
Bayer, A. J., Bayer, E. M., Pathy, M., & Stoker, M. J. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb10544.x · Cited by 33
Sleep disorders and their management
Gottlieb, G. L. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90283-j · Cited by 37
A Guide to Benzodiazepine Selection. Part II: Clinical Aspects
Teboul, E., & Chouinard, G. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600117 · Cited by 25
Pharmacological Treatment of Chronic Insomnia
Monti, J. M., & Monti, D. (1995) · CNS Drugs · doi:10.2165/00023210-199504030-00003 · Cited by 26
O’Donovan, M. C., & McGuffin, P. (1993) · BMJ · doi:10.1136/bmj.306.6883.945 · Cited by 27
Early morning insomnia, daytime anxiety, and organic mental disorder associated with triazolam.
Tan, T. L., Bixler, E. O., Kales, A., Cadieux, R. J., & Goodman, A. L. (1985) · PubMed · Cited by 25
Self-citationIdiosyncratic side effects of short half‐life benzodiazepine hypnotics: Fact or fancy?
Jonas, J. M. (1992) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470070309 · Cited by 26
Kripke, D. F. (2006) · Springer eBooks · doi:10.1007/0-387-27682-3_15 · Cited by 24
Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles
Jochemsen, R., & Breimer, D. D. (1984) · Current Medical Research and Opinion · doi:10.1185/03007998409109545 · Cited by 22
Behavioral Treatment of Insomnia: The Wilford Hall Insomnia Program
Hryshko‐Mullen, A., Broeckl, L. S., Haddock, C. K., & Peterson, A. L. (2000) · Military Medicine · doi:10.1093/milmed/165.3.200 · Cited by 22
Turek, F. W. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90020-0 · Cited by 21
Lau, C. E., & Heatherington, A. C. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37120-4 · Cited by 22
Benzodiazepine Hypnotics and Insomnia
Kales, A. (1990) · Hospital Practice · doi:10.1080/21548331.1990.11704103 · Cited by 23
Self-citationKales, A., & Vgontzas, A. N. (1992) · PubMed · Cited by 22
Self-citationBehavioral Side Effects of Triazolam in Psychiatric Inpatients: Report of Five Cases
Soldatos, C. R., Sakkas, P. N., Bergiannaki, J. D., & Stefanis, C. N. (1986) · Annals of Pharmacotherapy · doi:10.1177/106002808602000418 · Cited by 22
Self-citationClinical Comparison of Benzodiazepine Hypnotics With Short and Long Elimination Half-Lives
Kales, A., Soldatos, C. R., & Vela‐Bueno, A. (1985) · Springer eBooks · doi:10.1007/978-94-009-4886-0_9 · Cited by 22
Self-citationPomara, N., Willoughby, L. M., Ritchie, J., Sidtis, J. J., Greenblatt, D. J., & Nemeroff, C. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300365 · Cited by 20
“…other symptoms of withdrawal reactions can develop between doses (Ashton, 1994; Cole and Kando, 1993; Hallstrom and Lader, 1981; Herman et al, 1987; Kales et al, 1983, 1987; Noyes et al, 1985, 1988; Pecknold, 1993; Risse et al, 1990; Schweizer and Rickels, 1998; Slak, 1986; Vgontzas et al, 1995;…”
BackgroundInpatient multidimensional management of treatment-resistant in somnia
Tan, T. L., Kales, J. D., Kales, A., Martin, E. D., Mann, L. D., & Soldatos, C. R. (1987) · Psychosomatics · doi:10.1016/s0033-3182(87)72535-3 · Cited by 20
Self-citationHockings, N., & Ballinger, B. R. (1983) · BMJ · doi:10.1136/bmj.286.6382.1949 · Cited by 18
Effects of loprazolam and of triazolam on psychological functions
Morgan, K., Adam, K., & Oswald, I. (1984) · Psychopharmacology · doi:10.1007/bf00427691 · Cited by 16
Effects of lormetazepam and of flurazepam on sleep.
Adám, K., & Oswald, I. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02386.x · Cited by 17
“Although lormetazepam is fairly rapidly eliminated, there was no evidence in our data of the early morning insomnia (Kales et al., 1983) reported for triazolam.”
BackgroundResultInfluentialBehavioral Approaches to Individual Differences in Substance Abuse
Barrett, R. J. (1985) · Springer eBooks · doi:10.1007/978-1-4757-9990-3_5 · Cited by 17
Nishino, S., & Mignot, E. J.-M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937040-00003 · Cited by 20
Generalised Anxiety Disorder: Guidelines for Diagnosis and Treatment
Hoehn‐Saric, R. (1998) · CNS Drugs · doi:10.2165/00023210-199809020-00002 · Cited by 15
“[97] On the other hand, in the elderly or in patients with liver disease, a benzodiazepine with a short half-life should be chosen to avoid accumulation and excessive sedation.”
Triazolam and Temazepam: Issues and Concerns Relevant to the Army Aviation Community
Caldwell, J. L., Comperatore, C. A., & Shanahan, D. F. (1992) · Defense Technical Information Center (DTIC) · Cited by 13
Comparison of Lorazepam and Flurazepam as Hypnotic Agents in Chronic Insomniacs
McClure, D. J., Walsh, J., Chang, H., Olah, A., Wilson, R., & Pecknold, J. C. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03101.x · Cited by 13
Moon, C. A. L., Ankier, S. I., & Hayes, G. R. (1985) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1985.tb07857.x · Cited by 12
Flumazenil and precipitated benzodiazepine withdrawal reaction
Schauben, J. L. (1992) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80447-3 · Cited by 11
Pomara, N., Willoughby, L. M., Ritchie, J., Sidtis, J. J., Greenblatt, D. J., & Nemeroff, C. B. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0088-2 · Cited by 12
“We hypothesized that this elevation might represent an early manifestation of alprazolam dependence and/or withdrawal, based on reports of elevations in cortisol after gradual withdrawal of alprazolam (Mellman and Uhde 1986) and rebound anxiety during treatment with therapeutic doses of this agent (Cole and Kando 1993…”
BackgroundRegulatory Science As Culture: Contested Two-dimensional Values at the US FDA
Abraham, J. M. (2002) · Science as Culture · doi:10.1080/0950543022000005069 · Cited by 11
“Some doctors associated the drug with aggression, amnesia, anxiety, depression and even psychosis in patients, including homicidal and suicidal behaviour (Kales, 1983; Morgan and Oswald, 1982).”
BackgroundKales, J. D., Carvell, M., & Kales, A. (1990) · Springer eBooks · doi:10.1007/978-1-4757-2093-8_43 · Cited by 11
Self-citationLamphere, J. K., Roehrs, T., Zorick, F. J., Koshorek, G., & Roth, T. G. (1989) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470040107 · Cited by 11
Kubicki, S., Haag‐Wüsthof, C., Röhmel, J., Herrmann, W. M., & Scheuler, W. (1988) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470030404 · Cited by 11
Bixler, E. O., Kales, A., Manfredi, R. L., & Vgontzas, A. N. (1991) · The Lancet · doi:10.1016/0140-6736(91)92266-5 · Cited by 11
Self-citationDevelopment of physical dependence on midazolam by oral self-administration
Falk, J. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90613-7 · Cited by 11
Diagnosis and Management of Insomnia
(1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230714 · Cited by 11
Polysomnography in Drug Development
Dietrich, B. (1997) · The Journal of Clinical Pharmacology · doi:10.1177/009127009703700125 · Cited by 10
Hajak, G., Rüther, E., & Hauri, P. (1992) · Springer eBooks · doi:10.1007/978-3-642-75733-4_3 · Cited by 12
Methodological Issues in Pharmacological Studies of Sleep
Bixler, E. O., Vgontzas, A. N., & Kales, A. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_12 · Cited by 9
Self-citationSafety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Busto, U., Naranjo, C. A., Bremner, K. E., Peachey, J. E., & Bologa, M. (1998) · PubMed Central · Cited by 9
Sleep/Wake Cycle and Circadian Disturbances in Shift Work: Strategies for Their Management—A Review
Goh, V. H. H., Tong, T., & Lee, L. K. (2000) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v29n1p90 · Cited by 10
Recent advances in the clinical pharmacology of benzodiazepines part I: Pharmacokinetics
Saletu, B., & Pakesch, G. (1987) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470020103 · Cited by 9
Kursawe, H. K., & Kubicki, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-19943-1_5 · Cited by 6
The Triazolam Experience in 1979 in The Netherlands, a Problem of Signal Generation and Verification
Meyboom, R. H. B. (1992) · Springer eBooks · doi:10.1007/978-1-4899-2587-9_19 · Cited by 7
Salzman, C., & Nevis-Olesen, J. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-101277-9.50030-9 · Cited by 8
Addictions aux benzodiazépines: prévalence, diagnostic et traitement
Cloos, J. M., Stein, R., Rauchs, P., Koch, P., & Chouinard, G. (2011) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(11)55586-5 · Cited by 8
Jerram, T. C. (1984) · Side effects of drugs annual · doi:10.1016/s0378-6080(84)80009-4 · Cited by 6
Recent advances in the clinical pharmacology of benzodiazepines part II: Pharmacodynamics
Saletu, B., & Pakesch, G. (1987) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470020203 · Cited by 6
Die Beeinflussung des Schlafs durch Hypnotika
Borbély, A. A. (1992) · Springer eBooks · doi:10.1007/978-3-642-75733-4_4 · Cited by 10
Daytime consumption of triazolam
Martínez-Cano, H., & Vela‐Bueno, A. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03458.x · Cited by 5
Hajak, G., Herrendorf, G., & Rüther, E. (1993) · Springer eBooks · doi:10.1007/978-3-642-77111-8_13 · Cited by 5
Midazolam withdrawal and discriminative motor control: Effects of FG 7142 and Ro 15-1788
Vigorito, M., Lau, C. E., Tang, M., & Falk, J. L. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90191-4 · Cited by 4
Bénéfices et inconvénients des hypnotiques
Benoit, O. (1991) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(05)80374-0 · Cited by 6
(1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252412 · Cited by 4
Pentobarbital blocks the pentylenetetrazole‐like effect of withdrawal from chronic diazepam
Mathis, D. A., & Emmett‐Oglesby, M. W. (1989) · Drug Development Research · doi:10.1002/ddr.430160222 · Cited by 3
British Medical Journal Publishing Group (1983) · BMJ · doi:10.1136/bmj.287.6387.289-c · Cited by 3
Kilpatrick, C. J. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60072-2_15 · Cited by 3
Schlafstörungen: Häufigkeit — Ursachen — medikamentöse Behandlung
Rüther, E., & Engfer, A. (1988) · Vieweg+Teubner eBooks · doi:10.1007/978-3-663-20215-8_1 · Cited by 3
Sleep Disturbances as Side Effects of Therapeutic Drugs
Kales, A., & Vgontzas, A. N. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_20 · Cited by 4
Self-citationDiazepam (Valium): Its Dependency Liability
Murray, J. B. (1990) · The Journal of Psychology · doi:10.1080/00223980.1990.10543259 · Cited by 3
Metadata
- Authors
- Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D.
- Affiliations
- Pennsylvania State University (US)
- Venue
- Science
- Published
- 1983-04
- Volume
- 220
- Issue
- 4592
- Pages
- 95-97
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1984857603
- Cited by
- 138
- References
- 18
- Citations by year
- 2024: 2 · 2023: 1 · 2019: 1 · 2015: 1 · 2012: 1
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Keywords
- benzodiazepines, rebound insomnia, benzodiazepine tolerance, sedative-hypnotic drugs
- MeSH terms
- Benzodiazepines, Flurazepam, Half-Life, Humans, Sleep Initiation and Maintenance Disorders, Midazolam, Sleep, Anti-Anxiety Agents, Triazolam
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.